Guardian Pharmacy Services Inc

Research Guardian Pharmacy Services Inc (GRDN) on Bullrun: valuation model: 12.0% overvalued, market cap USD 2.36B, P/E 36.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Guardian Pharmacy Services Inc as 12.0% overvalued; latest market cap is USD 2.36B; P/E is 36.0.

Peer valuation comparison

Latest P/E is 36.04x versus a Healthcare sector median of 24.46x (47.3% above).

Latest P/E is 36.04x versus a United States median of 24.87x (44.9% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 1.45BUSD 49.22MUSD 86.84M20.2%0.77USD 65.62MUSD 0USD 217.92M
FY2024USD 1.23B-USD 110.05MUSD 43.25M19.9%-1.81USD 4.66MUSD 0USD 149.98M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 2.36B36.0n/an/a
20252025-12-31USD 1.91B38.6n/an/a
20242024-12-31USD 1.28Bn/an/an/a

About Guardian Pharmacy Services Inc

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes.

Related stock research

Other Healthcare stocks

Frequently asked questions

Is Guardian Pharmacy Services Inc overvalued or undervalued?

Bullrun's valuation model currently marks Guardian Pharmacy Services Inc as 12.0% overvalued.

What is Guardian Pharmacy Services Inc's market cap?

Guardian Pharmacy Services Inc's market capitalization is USD 2.36B.

What is Guardian Pharmacy Services Inc's P/E ratio?

Guardian Pharmacy Services Inc's price-to-earnings (P/E) ratio is 36.0.

What does Guardian Pharmacy Services Inc do?

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes.